
Indian Journal of Pharmacy Practice · Archive
Volumes & Issues
Open a volume to see its issues, then pick an issue for its cover art and complete table of contents.
Keyboard: use Up/Down arrows to move between volumes, Home/End to jump to the first or last, and Enter to open or close a volume.

In this issue
1–20 of 23Review Article
Review ArticlePublished: 8 Apr 2026
Souman Samanta, Sneha Sah
pp. 326-337 · DOI: 10.5530/ijopp.20260558Vol. 19, Issue 3 (2026)Pharmacovigilance (PV) and Clinical Data Management (CDM) are increasingly linked domains that are of enormous importance in ensuring the safety of drugs throughout the entire process. In the review, the evolving landsca…
Review ArticlePublished: 8 Apr 2026
Sudesh Sivakumar, Dhinesh Kumar Sambasivam, Suresh Kumar Krishnan
pp. 338-345 · DOI: 10.5530/ijopp.20260625Vol. 19, Issue 3 (2026)Nanotechnology has profoundly transformed Drug Delivery Systems (DDS), with Inorganic Nanoparticles (INPs) emerging as promising and versatile carriers owing to their exceptional stability, tunable size, and unique physi…
Original Article
Original ArticlePublished: 8 Apr 2026
Syed Zia Inamdar, Sushil Kumar Londhe, Hadi Abdul, Patil Rakshit, Patil Mallanagouda
pp. 346-351 · DOI: 10.5530/ijopp.20260676Vol. 19, Issue 3 (2026)Drug-Related Problems (DRPs) are common in hospitalized pediatric patients and may adversely affect therapeutic outcomes. The present study aimed to assess the prevalence and pattern of DRPs in pediatric inpatients and t…
Original ArticlePublished: 8 Apr 2026
Asha Pillai, Susan Uthup
pp. 352-360 · DOI: 10.5530/ijopp.20260677Vol. 19, Issue 3 (2026)Introduction: Nephrotic syndrome is a prevalent disorder in children, marked by the abnormal excretion of protein from the bloodstream into the urine due to compromised glomeruli. Conventional treatments such as corticos…
Original ArticlePublished: 8 Apr 2026
Pooja Panchawat, Manish Dhakar, Narendra Bheemraj Parihar, Renu Mishra, Mahendra Singh Rathore
pp. 361-366 · DOI: 10.5530/ijopp.20260680Vol. 19, Issue 3 (2026)Background: Platinum-based chemotherapy, including cisplatin and carboplatin, is a standard treatment for head and neck cancers. However, Gastrointestinal (GI) toxicity remains a common adverse effect that may affect tre…
Original ArticlePublished: 8 Apr 2026
Syed Zia Inamdar, Inamul Hoque, Sushil Kumar Londhe, Sandeep Patil, Bentoor Sanjeev, Siddanagouda Biradar, Ramakanth Baloorkar, Santosh Patil
pp. 367-373 · DOI: 10.5530/ijopp.20260687Vol. 19, Issue 3 (2026)Background: Chronic Kidney Disease (CKD) is an increasing global health challenge that significantly influences drug pharmacokinetics and pharmacodynamics. Impaired renal function reduces drug clearance, raising the like…
Original ArticlePublished: 8 Apr 2026
Chetan Malviya, Narendra Bheemraj Parihar, Manish Dhakar, Sunil Vishnoi, Ritesh Kumar, Mahendra Singh Rathore, Lalit Shrimali
pp. 374-379 · DOI: 10.5530/ijopp.20260685Vol. 19, Issue 3 (2026)Introduction: Proton Pump Inhibitors (PPIs) are among the most frequently prescribed drugs for the management and prevention of acid-related gastrointestinal disorders. Although PPIs are effective and well tolerated, the…
Original ArticlePublished: 8 Apr 2026
Kumar Masum, Shibi Mary Thomas, Balakeshwa Ramaiah
pp. 380-388 · DOI: 10.5530/ijopp.20260707Vol. 19, Issue 3 (2026)Introduction: Breast cancer is common in India, with variable responses to Neoadjuvant Chemotherapy (NACT), which is essential for tumor downstaging, breast conservation, and prognostic assessment. This study evaluated t…
Case Report
Case ReportPublished: 8 Apr 2026
Muhammed Salah, Muhammed Shas, Nahdha K, Shariba Parveen, Anjali C S, Kameswaran R, Sirajudheen M K
pp. 389-391 · DOI: 10.5530/ijopp.20260569Vol. 19, Issue 3 (2026)Lichen Planus Pigmentosus (LPP) is a rare variant of lichen planus that presents as dark brown to grey hyperpigmented macules over sun-exposed areas such as the face, neck, and upper limbs. This case report aims to descr…
Case ReportPublished: 8 Apr 2026
C. Dhandapani, Kavitha A
pp. 392-394 · DOI: 10.5530/ijopp.20260604Vol. 19, Issue 3 (2026)Acute Myeloid Leukemia (AML) with mixed phenotypic features represents a rare and high-risk subset of childhood leukemia. This case highlights a pediatric patient harboring a novel ZNF348/ SF11 fusion and NRAS mutation, …
Case ReportPublished: 8 Apr 2026
Niya Catherine
pp. 395-396 · DOI: 10.5530/ijopp.20260477Vol. 19, Issue 3 (2026)Etoricoxib is a COX 2 selective inhibitor it has one of the highest cox 2 selectivity and is one of the newer coxib class drug. Etoricoxib is an orally active cox 2 selective inhibitor that acts by blocking the cox 2 enz…
Case ReportPublished: 8 Apr 2026
Parshant Pokhriyal, Muskan Kumari, Damini Kharb, Subodh Gururani, Anuj Nautiyal
pp. 397-402 · DOI: 10.5530/ijopp.20260514Vol. 19, Issue 3 (2026)Dry gangrene is a severe complication of vascular insufficiency, often associated with Peripheral Arterial Disease (PAD), diabetes, or autoimmune conditions like Rheumatoid Arthritis (RA). This case report presents a pat…
Case ReportPublished: 8 Apr 2026
Syed Zia Inamdar, Chirasini Swapna, Pavan Kumar, Sushilkumar Londhe, Sanjeev Bentoor, Ajith Janagond, Shrinivas Raikar
pp. 403-406 · DOI: 10.5530/ijopp.20260623Vol. 19, Issue 3 (2026)Toxic Epidermal Necrolysis (TEN) is a rare, life-threatening mucocutaneous disorder, most often triggered by medications and less frequently by infections. It is clinically characterized by widespread erythema, epidermal…
Case ReportPublished: 8 Apr 2026
Sukesh Edavalath, Shahsadhi Ittikapparambil Palakkal, Shinad Achamveetil
pp. 407-410 · DOI: 10.5530/ijopp.20260594Vol. 19, Issue 3 (2026)Reactive arthritis is a rare complication following Bacillus Calmette-Guérin (BCG) therapy for bladder cancer, often presenting with joint pain and systemic symptoms. A patient with high-risk non-muscle-invasive bladder …
Case ReportPublished: 8 Apr 2026
Prathap Arumugam, Angelin Grace Thomas, Ann Jency Arul Durai Singam, Dhivyaprasath Palaniyappan
pp. 411-415 · DOI: 10.5530/ijopp.20260554Vol. 19, Issue 3 (2026)A 73-year-old female with fever, muscle weakness, and back pain was diagnosed with Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP), a subtype of Guillain-Barré Syndrome (GBS). Laboratory findings showed el…
Case ReportPublished: 8 Apr 2026
Idris Dawaiwala, Soniya Bhagat, Kapil Zirpe, Aniket Shah, Abhijeet Deshmukh, Prasad Muglikar
pp. 416-419 · DOI: 10.5530/ijopp.20260624Vol. 19, Issue 3 (2026)Polymyxin B is a last-line therapy for multidrug-resistant Gram-negative infections, with nephrotoxicity and neurotoxicity being the most recognized adverse effects. Cutaneous and vascular complications are rare and unde…
Case ReportPublished: 8 Apr 2026
Shaik Sharmila, Pavan Kumar Yanamadala, Janani Gope, Damini Sai Kumar Jammula, Bhargavi Devi Mandarapu, Rama Rao Nadendla
pp. 420-425 · DOI: 10.5530/ijopp.20260662Vol. 19, Issue 3 (2026)Background: Pseudo-Foster Kennedy Syndrome (PFKS) represents an uncommon neuro-ophthalmic condition distinguished by the presence of ipsilateral optic atrophy alongside contralateral papilledema, occurring in the absence…
Case ReportPublished: 8 Apr 2026
Atiya Rajgoli, Aiiravat Tambe, Ishan Tewari, Mandati Santhosh Reddy, Pratiksha Kini, Bhavana Doshi
pp. 426-430 · DOI: 10.5530/ijopp.20260656Vol. 19, Issue 3 (2026)Lichenoid Drug Eruption (LDE) is a rare, immune-mediated adverse cutaneous reaction that closely mimics idiopathic lichen planus. Isoniazid, a first-line anti-tubercular drug, has been infrequently implicated as a causat…
Case ReportPublished: 8 Apr 2026
Angelin Grace Thomas, Aswini Suresh, Ann Jency Arul Durai Singam
pp. 431-434 · DOI: 10.5530/ijopp.20260673Vol. 19, Issue 3 (2026)Costochondritis is a self-limiting inflammatory condition affecting the costochondral and chondrosternal joints, often presenting with localised chest pain. This case report discusses a 50-year-old male with a history of…
Case ReportPublished: 8 Apr 2026
Tellagorla Bharathi, Siram Teja Manikanta, Viswanadhapalli Jaswanth Raju, Katragadda Pradeepthi, Ghanta Vijayakumar, Ghanta Vijaya Kumar
pp. 435-437 · DOI: 10.5530/ijopp.20260688Vol. 19, Issue 3 (2026)The antithyroid drug methimazole is used to treat patients with hyperthyroidism. Agranulocytosis is a rare and life-threatening adverse effect of the drug, characterized by a reduced circulating white blood cell count, w…
